These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 25529572)

  • 1. Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery.
    Pavot V; Berthet M; Rességuier J; Legaz S; Handké N; Gilbert SC; Paul S; Verrier B
    Nanomedicine (Lond); 2014 Dec; 9(17):2703-18. PubMed ID: 25529572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface-assembled poly(I:C) on PEGylated PLGA microspheres as vaccine adjuvant: APC activation and bystander cell stimulation.
    Hafner AM; Corthésy B; Textor M; Merkle HP
    Int J Pharm; 2016 Nov; 514(1):176-188. PubMed ID: 27863662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.
    Liu Q; Chen X; Jia J; Zhang W; Yang T; Wang L; Ma G
    ACS Nano; 2015 May; 9(5):4925-38. PubMed ID: 25898266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.
    Jiang W; Gupta RK; Deshpande MC; Schwendeman SP
    Adv Drug Deliv Rev; 2005 Jan; 57(3):391-410. PubMed ID: 15560948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple and robust method for pre-wetting poly (lactic-co-glycolic) acid microspheres.
    Wright B; Parmar N; Bozec L; Aguayo SD; Day RM
    J Biomater Appl; 2015 Aug; 30(2):147-59. PubMed ID: 25791685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.
    Jaganathan KS; Singh P; Prabakaran D; Mishra V; Vyas SP
    J Pharm Pharmacol; 2004 Oct; 56(10):1243-50. PubMed ID: 15482638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resorbable lamellar particles of polylactide as adjuvants for influenza virus vaccines.
    Coombes AG; Major D; Wood JM; Hockley DJ; Minor PD; Davis SS
    Biomaterials; 1998 Jun; 19(11-12):1073-81. PubMed ID: 9692806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
    Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
    Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D,L-lactic-co-glycolic acid) microspheres: morphological effect on protein release.
    Kim HK; Park TG
    J Control Release; 2004 Jul; 98(1):115-25. PubMed ID: 15245894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High glycolic poly (DL lactic co glycolic acid) nanoparticles for controlled release of meropenem.
    Nandakumar V; Geetha V; Chittaranjan S; Doble M
    Biomed Pharmacother; 2013 Jun; 67(5):431-6. PubMed ID: 23583192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLGA/PLA micro- and nanoparticle formulations serve as antigen depots and induce elevated humoral responses after immunization of Atlantic salmon (Salmo salar L.).
    Fredriksen BN; Grip J
    Vaccine; 2012 Jan; 30(3):656-67. PubMed ID: 22100638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
    Gupta RK; Chang AC; Siber GR
    Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotropic bacterial antigens.
    Kofler N; Ruedl C; Klima J; Recheis H; Böck G; Wick G; Wolf H
    J Immunol Methods; 1996 Jun; 192(1-2):25-35. PubMed ID: 8699019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential degradation rates in vivo and in vitro of biocompatible poly(lactic acid) and poly(glycolic acid) homo- and co-polymers for a polymeric drug-delivery microchip.
    Grayson AC; Voskerician G; Lynn A; Anderson JM; Cima MJ; Langer R
    J Biomater Sci Polym Ed; 2004; 15(10):1281-304. PubMed ID: 15559850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine.
    Thomas C; Rawat A; Hope-Weeks L; Ahsan F
    Mol Pharm; 2011 Apr; 8(2):405-15. PubMed ID: 21189035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants.
    Singh D; Somani VK; Aggarwal S; Bhatnagar R
    Mol Immunol; 2015 Dec; 68(2 Pt A):272-9. PubMed ID: 26442664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly-(lactic-co-glycolic-acid)-based particulate vaccines: particle uptake by dendritic cells is a key parameter for immune activation.
    Silva AL; Rosalia RA; Varypataki E; Sibuea S; Ossendorp F; Jiskoot W
    Vaccine; 2015 Feb; 33(7):847-54. PubMed ID: 25576216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant.
    Hafner AM; Corthésy B; Merkle HP
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1386-99. PubMed ID: 23751781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling degradation of acid-hydrolyzable pluronic hydrogels by physical entrapment of poly(lactic acid-co-glycolic acid) microspheres.
    Lee JB; Chun KW; Yoon JJ; Park TG
    Macromol Biosci; 2004 Oct; 4(10):957-62. PubMed ID: 15487026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(lactic acid)-based particulate systems are promising tools for immune modulation.
    Peres C; Matos AI; Conniot J; Sainz V; Zupančič E; Silva JM; Graça L; Sá Gaspar R; Préat V; Florindo HF
    Acta Biomater; 2017 Jan; 48():41-57. PubMed ID: 27826003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.